Back to Search
Start Over
Oncology Drug Reference Sheet: Elacestrant.
- Source :
-
ONS Voice . 7/6/2023, p1-1. 1p. - Publication Year :
- 2023
-
Abstract
- The article provides information on elacestrant, an estrogen receptor (ER) antagonist which was granted by the U.S. Food and Drug Administration an application priority review and fast-track designation, with regular approval in January 2023. Topics discussed include dosing and administration, adverse reactions, and nursing considerations.
Details
- Language :
- English
- ISSN :
- 24756938
- Database :
- Academic Search Index
- Journal :
- ONS Voice
- Publication Type :
- Academic Journal
- Accession number :
- 182075290